Related Experiment Video

Updated: Jul 21, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

Cerebral ventricles are smaller in Hispanic than non-Hispanic patients with Alzheimer's disease

A Minagar1, S Sevush, A Bertran

  • 1Department of Neurology, University of Miami School of Medicine, FL 33101, USA.

Neurology
|August 10, 2000
PubMed

Insights

Hispanic patients with probable Alzheimer's disease (AD) showed smaller ventricular size compared to white non-Hispanic patients on MRI scans. This study highlights potential ethnic differences in brain structure among AD patients.

Area of Science:

  • Neuroimaging
  • Neurology
  • Alzheimer's Disease Research

Background:

  • Alzheimer's disease (AD) diagnosis relies on clinical criteria and biomarkers.
  • Ethnic variations in AD prevalence and progression are increasingly recognized.
  • Understanding neuroanatomical differences across ethnic groups is crucial for personalized medicine.

Purpose of the Study:

  • To compare brain structure, specifically ventricular size, cortical atrophy, and white matter hyperintensities, between Hispanic and white non-Hispanic patients with probable AD.
  • To investigate potential ethnic differences in neuroimaging markers associated with Alzheimer's disease.

Main Methods:

  • Magnetic Resonance Imaging (MRI) scans were analyzed from 71 Hispanic and 73 white non-Hispanic patients meeting criteria for National Institute of Neurological Disorders and Stroke (NINDS) probable AD.
  • Analysis of covariance (ANCOVA) was employed to compare neuroimaging metrics while controlling for age, sex, education, and Mini-Mental State Examination (MMSE) scores.

Main Results:

  • Hispanic patients exhibited significantly smaller ventricular volumes compared to white non-Hispanic patients (p = 0.0003).
  • No significant differences were observed between the groups regarding the extent of cortical atrophy.
  • T2-weighted white matter hyperintensities did not differ significantly between the Hispanic and white non-Hispanic patient groups.

Conclusions:

  • Ventricular size on MRI may represent a neuroimaging marker that differs between Hispanic and white non-Hispanic individuals with probable AD.
  • Further research is warranted to explore the clinical implications of these observed ethnic differences in brain structure.
  • These findings contribute to a growing body of evidence on ethnic variations in Alzheimer's disease neurobiology.

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Related Concept Videos

Anatomy of the Brain: Ventricles01:18

Anatomy of the Brain: Ventricles

There are hollow fluid-filled cavities known as ventricles deep inside the human brain. There are two lateral ventricles, one in each cerebral hemisphere, and each has three different projections — the anterior, inferior, and posterior horns visible from the lateral side. A thin membrane called the septum pellucidum separates the two lateral ventricles. The slender third ventricle in the diencephalon is connected to each lateral ventricle via a channel called the interventricular foramen. The...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...